CTNM
USDContineum Therapeutics Inc. Class A Common Stock
$10.390-0.370 (-3.439%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$10.760
High
$11.300
Low
$10.160
Volume
0.14M
Company Fundamentals
Market Cap
303.2M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.19M
Exchange
NMS
Currency
USD
52-Week Range
Low $3.35Current $10.390High $20.24
Related News
BusinessWire
Contineum Therapeutics Reports Third-Quarter 2025 Financial Results; Affirms Key Clinical Development Milestones
- Topline data from the PIPE-307 Phase 2 VISTA trial for the treatment of relapsing-remitting multiple sclerosis (RRMS) is anticipated in the fourth quarter of 2025 - Initiation of a global Phase 2 clinical trial of
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.